| dc.contributor.author | Darendeliler, Emin | |
| dc.contributor.author | Holdenrieder, Stefan | |
| dc.contributor.author | Dalay, Nejat | |
| dc.contributor.author | Kovancilar, Muege | |
| dc.contributor.author | Deligezer, Ugur | |
| dc.contributor.author | Yaman, Fulya | |
| dc.contributor.author | Dizdar, Yavuz | |
| dc.date.accessioned | 2021-03-03T08:36:03Z | |
| dc.date.available | 2021-03-03T08:36:03Z | |
| dc.identifier.citation | Deligezer U., Yaman F., Darendeliler E., Dizdar Y., Holdenrieder S., Kovancilar M., Dalay N., "Post-treatment circulating plasma BMP6 mRNA and H3K27 methylation levels discriminate metastatic prostate cancer from localized disease", CLINICA CHIMICA ACTA, cilt.411, ss.1452-1456, 2010 | |
| dc.identifier.issn | 0009-8981 | |
| dc.identifier.other | vv_1032021 | |
| dc.identifier.other | av_186e1ccb-ea89-4d4f-bece-6fe7c688ed5d | |
| dc.identifier.uri | http://hdl.handle.net/20.500.12627/21729 | |
| dc.identifier.uri | https://doi.org/10.1016/j.cca.2010.05.040 | |
| dc.description.abstract | Background: We evaluated the utility of post-treatment plasma levels of the circulating bone-morphogenetic protein-6-specific mRNA (cBMP6 mRNA), cell-free DNA (cf-DNA), apoptotic nucleosomes and Histone H3 lysine 27 trimethylation (H3K27me3), in discriminating metastatic prostate cancer (PCa) from organ confined, locally controlled disease. | |
| dc.language.iso | eng | |
| dc.subject | Sağlık Bilimleri | |
| dc.subject | TIBBİ LABORATUVAR TEKNOLOJİSİ | |
| dc.subject | Klinik Tıp | |
| dc.subject | Klinik Tıp (MED) | |
| dc.subject | Tıp | |
| dc.title | Post-treatment circulating plasma BMP6 mRNA and H3K27 methylation levels discriminate metastatic prostate cancer from localized disease | |
| dc.type | Makale | |
| dc.relation.journal | CLINICA CHIMICA ACTA | |
| dc.contributor.department | İstanbul Üniversitesi , , | |
| dc.identifier.volume | 411 | |
| dc.identifier.startpage | 1452 | |
| dc.identifier.endpage | 1456 | |
| dc.contributor.firstauthorID | 197668 | |
